{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T02:03:37Z","timestamp":1780625017923,"version":"3.54.1"},"reference-count":71,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:00:00Z","timestamp":1626307200000},"content-version":"vor","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.heliyon.2021.e07615","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T12:59:39Z","timestamp":1626440379000},"page":"e07615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["N-acetyl cysteine administration affects cerebral blood flow as measured by arterial spin labeling MRI in patients with multiple sclerosis"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7420-4183","authenticated-orcid":false,"given":"Shiva","family":"Shahrampour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5557-8841","authenticated-orcid":false,"given":"Justin","family":"Heholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faezeh","family":"Vedaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0764-0612","authenticated-orcid":false,"given":"Feroze B.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Alizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8339-5567","authenticated-orcid":false,"given":"Ze","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Zabrecky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6226-3960","authenticated-orcid":false,"given":"Nancy","family":"Wintering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Bazzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8924-8891","authenticated-orcid":false,"given":"Thomas P.","family":"Leist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Monti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8230-1752","authenticated-orcid":false,"given":"Andrew B.","family":"Newberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.heliyon.2021.e07615_bib1","first-page":"175","article-title":"Multiple sclerosis review","volume":"37","author":"Goldenberg","year":"2012","journal-title":"PT"},{"issue":"8","key":"10.1016\/j.heliyon.2021.e07615_bib2","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2217\/bmm-2016-0097","article-title":"Oxidative stress-related biomarkers in multiple sclerosis: a review","volume":"10","author":"Ibitoye","year":"2016","journal-title":"Biomarkers Med."},{"issue":"1152","key":"10.1016\/j.heliyon.2021.e07615_bib3","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1098\/rstb.1985.0168","article-title":"Oxidative stress: damage to intact cells and organs","volume":"311","author":"Sies","year":"1985","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"issue":"10","key":"10.1016\/j.heliyon.2021.e07615_bib4","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.3390\/nu4101399","article-title":"Dysregulation of glutathione homeostasis in neurodegenerative diseases","volume":"4","author":"Johnson","year":"2012","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.heliyon.2021.e07615_bib5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bbadis.2010.06.011","article-title":"Radical changes in multiple sclerosis pathogenesis","volume":"1812","author":"van Horssen","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.heliyon.2021.e07615_bib6","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1515\/BC.2003.059","article-title":"Glutathione pathways in the brain","volume":"384","author":"Dringen","year":"2003","journal-title":"Biol. Chem."},{"key":"10.1016\/j.heliyon.2021.e07615_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0076-6879(95)51106-7","article-title":"Glutathione metabolism","volume":"251","author":"Meister","year":"1995","journal-title":"Methods Enzymol."},{"issue":"3","key":"10.1016\/j.heliyon.2021.e07615_bib8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/1352458510384010","article-title":"Lower levels of glutathione in the brains of secondary progressive multiple sclerosis patients measured by 1H magnetic resonance chemical shift imaging at 3 T","volume":"17","author":"Choi","year":"2011","journal-title":"Mult. Scler."},{"key":"10.1016\/j.heliyon.2021.e07615_bib9","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neuroscience.2012.05.062","article-title":"The reduced glutathione and S-nitrosothiols levels in acute phase of experimental demyelination-pathophysiological approach and possible clinical relevancy","volume":"219","author":"Ljubisavljevic","year":"2012","journal-title":"Neuroscience"},{"issue":"11","key":"10.1016\/j.heliyon.2021.e07615_bib10","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1177\/1352458514533400","article-title":"Glutathione in multiple sclerosis: more than just an antioxidant?","volume":"20","author":"Carvalho","year":"2014","journal-title":"Mult. Scler."},{"issue":"12","key":"10.1016\/j.heliyon.2021.e07615_bib11","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/glia.20543","article-title":"Astrocyte control of the cerebrovasculature","volume":"55","author":"Gordon","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.heliyon.2021.e07615_bib12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.neuroscience.2018.03.018","article-title":"Neurovascular coupling during visual stimulation in multiple sclerosis: a MEG-fMRI study","volume":"403","author":"Stickland","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/j.heliyon.2021.e07615_bib13","doi-asserted-by":"crossref","first-page":"806","DOI":"10.3389\/fphys.2018.00806","article-title":"Oxidative stress: a major player in cerebrovascular alterations associated to neurodegenerative events","volume":"9","author":"Carvalho","year":"2018","journal-title":"Front. Physiol."},{"issue":"5","key":"10.1016\/j.heliyon.2021.e07615_bib14","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/jnnp-2013-305612","article-title":"Reduced grey matter perfusion without volume loss in early relapsing-remitting multiple sclerosis","volume":"85","author":"Debernard","year":"2014","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"issue":"9","key":"10.1016\/j.heliyon.2021.e07615_bib15","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1136\/jnnp.2003.026021","article-title":"Abnormalities of cerebral perfusion in multiple sclerosis","volume":"75","author":"Rashid","year":"2004","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.heliyon.2021.e07615_bib16","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neurad.2016.10.001","article-title":"Hypoperfusion of the thalamus is associated with disability in relapsing remitting multiple sclerosis","volume":"44","author":"Doche","year":"2017","journal-title":"J.\u00a0Neuroradiol."},{"issue":"3","key":"10.1016\/j.heliyon.2021.e07615_bib17","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/1352458513495936","article-title":"Hypoperfusion and T1-hypointense lesions in white matter in multiple sclerosis","volume":"20","author":"Narayana","year":"2014","journal-title":"Mult. Scler."},{"issue":"Pt 3","key":"10.1016\/j.heliyon.2021.e07615_bib18","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/brain\/awv398","article-title":"The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain","volume":"139","author":"Haider","year":"2016","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.heliyon.2021.e07615_bib19","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S1474-4422(08)70259-X","article-title":"Cognitive impairment in multiple sclerosis","volume":"7","author":"Chiaravalloti","year":"2008","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.heliyon.2021.e07615_bib20","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1212\/WNL.0b013e3182616ff9","article-title":"A\u00a0randomized trial of stress management for the prevention of new brain lesions in MS","volume":"79","author":"Mohr","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.heliyon.2021.e07615_bib21","doi-asserted-by":"crossref","first-page":"100244","DOI":"10.1016\/j.ynstr.2020.100244","article-title":"Blunted neural and psychological stress processing predicts future grey matter atrophy in multiple sclerosis","volume":"13","author":"Meyer-Arndt","year":"2020","journal-title":"Neurobiol Stress"},{"issue":"4","key":"10.1016\/j.heliyon.2021.e07615_bib22","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/jnr.10408","article-title":"Nitric oxide synthase is present in the cerebrospinal fluid of patients with active multiple sclerosis and is associated with increases in cerebrospinal fluid protein nitrotyrosine and S-nitrosothiols and with changes in glutathione levels","volume":"70","author":"Calabrese","year":"2002","journal-title":"J.\u00a0Neurosci. Res."},{"issue":"Pt 7","key":"10.1016\/j.heliyon.2021.e07615_bib23","first-page":"1914","article-title":"Oxidative damage in multiple sclerosis lesions","volume":"134","author":"Haider","year":"2001","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.heliyon.2021.e07615_bib24","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/ane.13012","article-title":"Regional neuronal activity in patients with relapsing remitting multiple sclerosis","volume":"138","author":"Baumgartner","year":"2018","journal-title":"Acta Neurol. Scand."},{"issue":"2","key":"10.1016\/j.heliyon.2021.e07615_bib25","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.cld.2018.01.007","article-title":"Acetaminophen (APAP or N-Acetyl-p-Aminophenol) and acute liver failure","volume":"22","author":"Bunchorntavakul","year":"2018","journal-title":"Clin. Liver Dis."},{"issue":"4","key":"10.1016\/j.heliyon.2021.e07615_bib26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/WNF.0b013e31829ae713","article-title":"N-Acetylcysteine boosts brain and blood glutathione in Gaucher and Parkinson diseases","volume":"36","author":"Holmay","year":"2013","journal-title":"Clin. Neuropharmacol."},{"issue":"15","key":"10.1016\/j.heliyon.2021.e07615_bib27","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0024-3205(98)00472-X","article-title":"Hypothesis: can N-acetylcysteine be beneficial in Parkinson's disease?","volume":"64","author":"Martinez","year":"1999","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.heliyon.2021.e07615_bib28","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1179\/1351000211Y.0000000007","article-title":"Aminoguanidine and N-acetyl-cysteine supress oxidative and nitrosative stress in EAE rat brains","volume":"16","author":"Ljubisavljevic","year":"2011","journal-title":"Redox Rep."},{"issue":"1","key":"10.1016\/j.heliyon.2021.e07615_bib29","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1740-2557-2-4","article-title":"N-acetyl-L-cysteine ameliorates the inflammatory disease process in experimental autoimmune encephalomyelitis in Lewis rats","volume":"2","author":"Stanislaus","year":"2005","journal-title":"J.\u00a0Autoimmune Dis."},{"issue":"2","key":"10.1016\/j.heliyon.2021.e07615_bib30","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/brb3.208","article-title":"N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities","volume":"4","author":"Bavarsad Shahripour","year":"2014","journal-title":"Brain Behav"},{"key":"10.1016\/j.heliyon.2021.e07615_bib31","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fneur.2020.00088","article-title":"N-acetyl cysteine administration is associated with increased cerebral glucose metabolism in patients with multiple sclerosis: an exploratory study","volume":"11","author":"Monti","year":"2020","journal-title":"Front. Neurol."},{"issue":"9","key":"10.1016\/j.heliyon.2021.e07615_bib32","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.crad.2016.05.010","article-title":"MRI differential diagnosis of suspected multiple sclerosis","volume":"71","author":"Chen","year":"2016","journal-title":"Clin. Radiol."},{"issue":"4","key":"10.1016\/j.heliyon.2021.e07615_bib33","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/WCO.0000000000000572","article-title":"MRI in multiple sclerosis: what is changing?","volume":"31","author":"Filippi","year":"2018","journal-title":"Curr. Opin. Neurol."},{"issue":"5","key":"10.1016\/j.heliyon.2021.e07615_bib34","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3348\/kjr.2014.15.5.554","article-title":"Perfusion magnetic resonance imaging: a comprehensive update on principles and techniques","volume":"15","author":"Jahng","year":"2014","journal-title":"Korean J. Radiol."},{"issue":"47","key":"10.1016\/j.heliyon.2021.e07615_bib35","doi-asserted-by":"crossref","first-page":"13444","DOI":"10.1073\/pnas.1605829113","article-title":"Stress-induced brain activity, brain atrophy, and clinical disability in multiple sclerosis","volume":"113","author":"Weygandt","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.heliyon.2021.e07615_bib36","article-title":"Early perfusion changes in multiple sclerosis patients as assessed by MRI using arterial spin labeling","volume":"8","author":"de la Pena","year":"2019","journal-title":"Acta Radiol Open"},{"issue":"4","key":"10.1016\/j.heliyon.2021.e07615_bib37","doi-asserted-by":"crossref","first-page":"646","DOI":"10.4103\/1673-5374.266906","article-title":"Relationship between MRI perfusion and clinical severity in multiple sclerosis","volume":"15","author":"Lagana","year":"2020","journal-title":"Neural Regen Res"},{"issue":"2","key":"10.1016\/j.heliyon.2021.e07615_bib38","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.heliyon.2021.e07615_bib39","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/jnnp.74.6.710","article-title":"Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson's disease with normal population health profiles","volume":"74","author":"Riazi","year":"2013","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.heliyon.2021.e07615_bib40","first-page":"99","article-title":"A\u00a0survey of multiple sclerosis, part 1: perceived cognitive problems and compensatory strategy use","volume":"4","author":"Sullivan","year":"1990","journal-title":"Can. J. Rehabil."},{"issue":"4","key":"10.1016\/j.heliyon.2021.e07615_bib41","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/0271678X17743240","article-title":"Arterial spin labeling for the measurement of cerebral perfusion and angiography","volume":"38","author":"Jezzard","year":"2018","journal-title":"J.\u00a0Cerebr. Blood Flow Metabol."},{"issue":"2","key":"10.1016\/j.heliyon.2021.e07615_bib42","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.mri.2007.07.003","article-title":"Empirical optimization of ASL data analysis using an ASL data processing toolbox: ASLtbx","volume":"26","author":"Wang","year":"2008","journal-title":"Magn. Reson. Imaging"},{"issue":"2","key":"10.1016\/j.heliyon.2021.e07615_bib43","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1148\/radiol.2282020409","article-title":"Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging","volume":"228","author":"Warmuth","year":"2003","journal-title":"Radiology"},{"key":"10.1016\/j.heliyon.2021.e07615_bib44","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jneumeth.2018.06.007","article-title":"Alzheimer\u2019s Disease Neuroimaging Initiative. Priors-guided slice-wise adaptive outlier cleaning for arterial spin labeling perfusion MRI","volume":"307","author":"Li","year":"2018","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.heliyon.2021.e07615_bib45","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.nicl.2013.04.014","article-title":"Arterial spin labeled MRI in prodromal Alzheimer's disease: a multi-site study","volume":"2","author":"Wang","year":"2013","journal-title":"NeuroImage Clinical"},{"key":"10.1016\/j.heliyon.2021.e07615_bib46","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.expneurol.2015.11.010","article-title":"Oxidative stress in multiple sclerosis: central and peripheral mode of action","volume":"277","author":"Ohl","year":"2016","journal-title":"Exp. Neurol."},{"issue":"12","key":"10.1016\/j.heliyon.2021.e07615_bib47","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.freeradbiomed.2008.09.023","article-title":"Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression","volume":"45","author":"van Horssen","year":"2008","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.heliyon.2021.e07615_bib48","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1152\/japplphysiol.00371.2004","article-title":"N-acetylcysteine enhances muscle cysteine and glutathione availability and attenuates fatigue during prolonged exercise in endurance-trained individuals","volume":"97","author":"Medved","year":"2004","journal-title":"J.\u00a0Appl. Physiol."},{"key":"10.1016\/j.heliyon.2021.e07615_bib49","doi-asserted-by":"crossref","DOI":"10.1123\/ijsnem.21.6.451","article-title":"N-acetylcysteine attenuates fatigue following repeated-bouts of intermittent exercise: practical implications for tournament situations","author":"Cobley","year":"2011","journal-title":"Int. J. Sport Nutr. Exerc. Metabol."},{"issue":"6","key":"10.1016\/j.heliyon.2021.e07615_bib50","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.clinbiochem.2012.01.023","article-title":"Peripheral oxidative stress in relapsing-remitting multiple sclerosis","volume":"45","author":"Tasset","year":"2012","journal-title":"Clin. Biochem."},{"issue":"Suppl 1","key":"10.1016\/j.heliyon.2021.e07615_bib51","first-page":"39","article-title":"Iron metabolism and Parkinson's disease","volume":"13","author":"Hirsch","year":"1998","journal-title":"Mov. Disord."},{"issue":"7","key":"10.1016\/j.heliyon.2021.e07615_bib52","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/aps.2009.72","article-title":"Neuron differentiation and neuritogenesis stimulated by N-acetylcysteine (NAC)","volume":"30","author":"Qian","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.heliyon.2021.e07615_bib53","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00606662","article-title":"Pharmacokinetics of N-acetylcysteine in man","volume":"31","author":"Borgstr\u00f6m","year":"1986","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.heliyon.2021.e07615_bib54","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF01061422","article-title":"Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine","volume":"34","author":"Olsson","year":"1988","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.heliyon.2021.e07615_bib55","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1123\/ijsnem.21.6.451","article-title":"N-Acetylcysteine's attenuation of fatigue after repeated bouts of intermittent exercise: practical implications for tournament situations","volume":"21","author":"Cobley","year":"2011","journal-title":"Int. J. Sport Nutr. Exerc. Metabol."},{"key":"10.1016\/j.heliyon.2021.e07615_bib56","article-title":"Repeated-dose oral N-Acetylcysteine in Multiple sclerosis: pharmacokinetics and effect on brain glutathione and oxidative stress","author":"Coles","year":"2017","journal-title":"J.\u00a0Clin. Pharmacol."},{"key":"10.1016\/j.heliyon.2021.e07615_bib57","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.neuroscience.2017.07.055","article-title":"Neuroimaging techniques to assess inflammation in multiple sclerosis","volume":"403","author":"Tommasin","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/j.heliyon.2021.e07615_bib58","doi-asserted-by":"crossref","DOI":"10.1002\/cpt.1548","article-title":"N-acetyl cysteine is associated with dopaminergic improvement in Parkinson's disease","author":"Monti","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"issue":"6 Pt 1","key":"10.1016\/j.heliyon.2021.e07615_bib59","first-page":"1186","article-title":"Fatigue in multiple sclerosis is associated with abnormal cortical activation to voluntary movement-EEG evidence","volume":"13","author":"Leocani","year":"2021","journal-title":"Neuroimage"},{"key":"10.1016\/j.heliyon.2021.e07615_bib60","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3389\/fneur.2018.00828","article-title":"CBF in multiple sclerosis: recent findings and future directions","volume":"9","author":"Tahedl","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.heliyon.2021.e07615_bib61","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1177\/0269881108093271","article-title":"Cholinergic agonism alters cognitive processing and enhances brain CBF in patients with multiple sclerosis","volume":"23","author":"Cader","year":"2009","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.heliyon.2021.e07615_bib62","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s11910-012-0294-3","article-title":"Cognitive impairment in multiple sclerosis","volume":"12","author":"Lovera","year":"2012","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.heliyon.2021.e07615_bib63","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2174\/1570159X15666171109132650","article-title":"Pharmacological and non-pharmacological therapies of cognitive impairment in multiple sclerosis","volume":"16","author":"Miller","year":"2018","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.heliyon.2021.e07615_bib64","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1212\/WNL.41.5.685","article-title":"Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction","volume":"41","author":"Rao","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.heliyon.2021.e07615_bib65","doi-asserted-by":"crossref","first-page":"897","DOI":"10.12740\/PP\/32182","article-title":"Neuroimaging and genetic correlates of cognitive dysfunction in multiple sclerosis","volume":"49","author":"Guenter","year":"2015","journal-title":"Psychiatr. Pol."},{"key":"10.1016\/j.heliyon.2021.e07615_bib66","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1177\/1352458513495584","article-title":"The link between resting-state CBF and cognition in MS patients","volume":"20","author":"Cruz-G\u00f3mez","year":"2014","journal-title":"Mult. Scler."},{"key":"10.1016\/j.heliyon.2021.e07615_bib67","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1002\/hbm.22505","article-title":"Brain networks disconnection in early multiple sclerosis cognitive deficits: an anatomofunctional study","volume":"35","author":"Louapre","year":"2014","journal-title":"Hum. Brain Mapp."},{"issue":"1","key":"10.1016\/j.heliyon.2021.e07615_bib68","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1038\/s41598-017-04353-w","article-title":"Discrepancy between objective and subjective cognition in adults with major depressive disorder","volume":"7","author":"Srisurapanont","year":"2017","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.heliyon.2021.e07615_bib69","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1080\/13803395.2019.1614535","article-title":"The relationship between physical activity and symptoms of fatigue, mood, and perceived cognitive impairment in adults with multiple sclerosis","volume":"41","author":"Mayo","year":"2019","journal-title":"J.\u00a0Clin. Exp. Neuropsychol."},{"issue":"5","key":"10.1016\/j.heliyon.2021.e07615_bib70","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jpsychores.2014.02.013","article-title":"Polypharmacy in multiple sclerosis: relationship with fatigue, perceived cognition, and objective cognitive performance","volume":"76","author":"Thelen","year":"2014","journal-title":"J.\u00a0Psychosom. Res."},{"issue":"4","key":"10.1016\/j.heliyon.2021.e07615_bib71","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/gps.4486","article-title":"Perceived stress and cognitive function in older adults: which aspect of perceived stress is important?","volume":"32","author":"Korten","year":"2017","journal-title":"Int. J. Geriatr. Psychiatr."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844021017187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844021017187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T17:32:27Z","timestamp":1773768747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844021017187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":71,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S2405844021017187"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2021.e07615","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-acetyl cysteine administration affects cerebral blood flow as measured by arterial spin labeling MRI in patients with multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2021.e07615","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e07615"}}